• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Abbott launches Lingo OTC CGM at Best Buy through Withings bundle

March 31, 2026 By Sean Whooley

Abbott Lingo x Withings smart scale
The Lingo OTC CGM with the Withings smart scale. [Image courtesy of Abbott]
Abbott (NYSE:ABT) today said it launched a new bundle with Withings for its Lingo over-the-counter glucose biosensor at Best Buy.

Lingo features a biosensor and mobile app designed for customers who want to improve their overall health and wellness. The company built Lingo on its FreeStyle Libre continuous glucose monitor (CGM) technology platform. The consumer biowearable is available for consumers 18 years and older not on insulin. It tracks glucose in real time and provides personal insights and coaching. The company designed it to help people build healthy habits, retain their metabolism and improve their overall well-being.

Abbott received FDA clearance for Lingo and its Libre Rio OTC CGMs in June 2024. Lingo is one of two OTC CGMs on the market, with Dexcom’s Stelo also an option for those seeking to monitor glucose levels.

Today, the company said its bundle, available on BestBuy.com, includes Lingo’s two-week sensor pack with Withings’ Body Smart scale. It provides a simple, all-in-one solution for tracking key health metrics, such as blood glucose and body composition, plus cardiovascular health and sleep.

Withings Abbott Lingo Glucose Data (1)
Lingo data offered through a partnership with Withings. [Image courtesy of Abbott/Withings]
Lingo glucose data syncs directly with the Withings app after the companies announced integration at the start of 2026.

Best Buy is the latest retailer to add Lingo to its offerings. Abbott announced a launch through Amazon as its first retail agreement for the device in 2025, then with Walmart as the first brick-and-mortar retailer for the CGM.

In December 2025, Abbott unveiled Lingo compatibility with Android devices as well, then launched the OTC CGM at Walgreens.

Commentary from Abbott and Withings leadership

Olivier Ropars, division VP of Abbott’s Lingo business, said:

“With Lingo now fully integrated into the Withings app, consumers can more easily understand how their daily choices influence glucose and their broader health through one seamless, connected experience. Bringing Lingo to BestBuy.com makes these metabolic insights available through a trusted destination, offering people easier access to tools that help them engage with their health.”

Aline Criton, chief medical officer of Withings, said:

“Glucose is one of the most powerful real-time indicators of metabolic health, offering a direct window into how the body responds to daily behaviors. By integrating Lingo into the Withings ecosystem, we enable users to see glucose alongside key health signals like body composition, sleep, and activity—unlocking a more holistic, actionable understanding of their health.”

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: abbott, Withings

IN CASE YOU MISSED IT

  • Tandem Diabetes Care names successor as CEO Sheridan retires
  • MiniMed names new CMO ahead of planned retirement
  • Insulet earnings trounce Q3 estimates as it narrows guidance
  • Dexcom Q3 earnings top forecasts, as it looks ahead to type 2 coverage
  • Sensonics launches human feasibility study for transmitter-free Eversense CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS